Cardiovascular Disease Hypertension Data Focussed Commentary

Cardiovascular Disease - Hypertension banner

To visit another floor: Press the lift button, use the HTML version, or go to the reception
.

Data focussed Commentary

Knowledge Laboratory

- Case Studies

- Quizzes

Library

Patient Decision Aids

Workshops

- <60 minute eLearning event

- Key slides

Information Mastery 1 - Introduction
Information Mastery 2 - Skills
CV - Background
CV - Risk Assessment
Lifestyle
CV - lipids
NPCi blog - Cardiovascular disease

NICE Guidance on Hypertension - CG34
NICE guidance on type 2 diabetes (update) - CG87
Clinical Knowledge Summary (PRODIGY) Hypertension
BHS, How to measure blood pressure

Please help us to improve this site by filling in our feedback form

Cardiovascular (inc. Diabetes)

Cardiovascular Disease - Hypertension -

Data Focussed Commentary

Cardiovascular Disease - Hypertension

Changes/additions to materials

29th March 2010: NICE has reissued its guideline on cardiovascular risk assessment and lipid modification (CG67) removing the recommendation to use a specific method for risk estimation (based on the Framingham equation). NICE considered new evidence relating to QRISK but concluded that it was not able to recommend one cardiovascular risk estimation method over another. It has therefore left the decision to the NHS locally to use the method best suited to their requirements. All other recommendations in the guideline are unchanged.

Hypertension Data Focussed Commentary

We have produced data-focussed commentaries to highlight areas where there appear to be differences between the evidence-base, as described elsewhere on this floor, and current clinical practice. These resources can be read on the screen by clicking the 'flash' version, or by downloading and printing the 'PDF' version.

This commentary covers ACEis, A2RAs, alpha blockers, calcium channel blockers and thiazides.

Flash	Click here to view the Hypertension Data Focussed Commentary online
PDF	Download a copy of the Hypertension Data Focussed Commentary

Data focussed commentaries are written in the context of careful consideration of the available evidence. There are limits to the interpretation of data and assuming it is a true reflection of clinical practice. Nevertheless, we regard the issues represented within data focussed commentaries as being legitimate issues for debate.

> Terms & Conditions